Advertisement

Thalamic and Cortical Changes in Parkinsonian Disorders

  • Jasmine M. Henderson
  • Virginia Macdonald
  • Glenda M. Halliday
Conference paper
Part of the Advances in Behavioral Biology book series (ABBI, volume 56)

Keywords

Motor Cortex Progressive Supranuclear Palsy Supplementary Motor Area Subthalamic Nucleus Progressive Supranuclear Palsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

5. References

  1. Amano, N., Nagatomo, H., Yokoi, S., Yagishita, S., Siatoh, A., and Mizutani, T., 1992, The thalamic changes in progressive supranuclear palsy, No To Shinkei 44(5):421–428.PubMedGoogle Scholar
  2. Benabid, A., Pollak, P., Gervason, C., Hoffmann, D., Gao, D., Hommel, M., Perret, J., and de Rougemont, J., 1991, Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus, Lancet 337:403–406.PubMedCrossRefGoogle Scholar
  3. Berardelli, A., Rothwell, J.C., Hallett, M., Thompson, P.D., Manfredi, M., and Marsden, C.D., 1998, The pathophysiology of primary dystonia, Brain 121:1195–1212.PubMedCrossRefGoogle Scholar
  4. Bigio, E.H., Vono, M.B., Satumtira, S., Adamson, J., Sontag, E., Hynan, L.S., White, C.L., Baker, M., and Hutton, M., 2001, Cortical synapse loss in progressive supranuclear palsy, J. Neuropatho. Exp. Neurol. 60(5):403–410.Google Scholar
  5. Blin, J., Baron, J.C., Dubois, B., Pillon, B., Cambon, H., Cambier, J., and Agid, Y., 1990, Positron emission topography study in progressive supranuclear palsy, Brain hypometabolic pattern and clinicometabolic correlations, Arch. Neurol. 47:747–752.PubMedGoogle Scholar
  6. Cordato, N.J., Halliday, G.M., Harding, A.J., Hely, M.A., and Morris, J.G.L., 2000, Regional brain atrophy in progressive supranuclear palsy and Lewy body disease, Ann. Neurol. 47:718–728.PubMedCrossRefGoogle Scholar
  7. DeLong, M.R., 1990, Primate models of movement disorders of basal ganglia origin, Trends Neurosci. 13:281–285.PubMedCrossRefGoogle Scholar
  8. Dum, R.P., and Strick, P.L., 2002, Motor areas in the frontal lobe of the primate, Physiol. Behav. 77:677–682.PubMedCrossRefGoogle Scholar
  9. Fearnley, J., and Lees, A., 1991, Ageing and Parkinson’s disease: substantia nigra regional selectivity, Brain 114:2283–2301.PubMedGoogle Scholar
  10. Féger, J., Bevan, M., and Crossman, A., 1994, The projections from the parafascicular thalamic nucleus to the subthalamic nucleus and the striatum arise from separate neuronal populations: a comparison with the corticostriatal and corticosubthalamic efferents in a retrograde fluorescent double-labelling study, Neuroscience 60:125–132.PubMedCrossRefGoogle Scholar
  11. Fénelon, G., François, C., Percheron, G., and Yelnik, J., 1991, Topographic distribution of the neurons of the central complex (centre médian-parafascicular complex) and of other thalamic neurons projecting to the striatum in macaques, Neuroscience 45:495–510.PubMedCrossRefGoogle Scholar
  12. Fénelon, G., Yelnik, J., François, C., and Percheron, G., 1994, Central complex of the primate thalamus: a quantitative analysis of neuronal morphology, J. Comp. Neurol. 342:463–479.PubMedCrossRefGoogle Scholar
  13. Forno, L.S., 1996, Neuropathology of Parkinson’s disease, J. Neuropathol. Exp. Neurol. 55(3):259–272.PubMedGoogle Scholar
  14. Foster, N.L., Gilman, S., Berent, S., Morin, E.M., Brown, M.B., and Koeppe, R.A., 1988, Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography, Ann. Neurol. 24:399–406.PubMedCrossRefGoogle Scholar
  15. Fukuda, M., Mentis, M., Ma, Y., Antonini, A., Lang, A.E., Lozano, A., et al., 2001, Networks mediating the clinical effects of pallidal brain stimulation for Parkinson’s disease: A PET study of resting-state glucose metabolism, Brain 124:1601–1609.PubMedCrossRefGoogle Scholar
  16. Gai, W.P., Halliday, G.M., Blumbergs, P.C., Geffen, L.B., and Blessing, W.W., 1991, Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson’s disease, Brain 114:2253–2267.PubMedGoogle Scholar
  17. Gelb, D.J., Oliver, E., and Gilman, S., 1999, Diagnostic criteria for Parkinson’s disease, Arch. Neurol. 56:33–39.PubMedCrossRefGoogle Scholar
  18. Geyer, S., Matelli, M., Luppino, G., and Zilles, K., 2000, Functional neuroanatomy of the primate isocortical motor system, Anat. Embryol. 202:443–474.PubMedCrossRefGoogle Scholar
  19. Halliday, G.M., Blumbergs, P.C., Cotton, R.G.H., Blessing, W.W., and Geffen, L.B., 1990, Loss of brainstem serotonin-and substance P-containing neurons in Parkinson’s disease, Brain Res. 510:104–107.PubMedCrossRefGoogle Scholar
  20. Halliday, G.M., McRitchie, D.A., Cartwright, H.R., Pamphlett, R.S., Hely, M.A., and Morris, J.G.L., 1996, Midbrain neuropathology in idiopathic Parkinson’s disease and diffuse Lewy body disease, J. Clin. Neurosci. 3:52–60.CrossRefPubMedGoogle Scholar
  21. Hanihara, T., Amano, N., Takahashi, T., Nagatomo, H., and Yagashita, S., 1995, Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy, Neuropath. Appl. Neurobiol. 21:319–326.CrossRefGoogle Scholar
  22. Hanyu, H., Asano, T., Sakurai, H., Takasaki, M., Shindo, H., and Abe, K., 2001, Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson’s disease with and without dementia and in progressive supranuclear palsy, Neuroradiology 43(7):542–546.PubMedCrossRefGoogle Scholar
  23. Harding, A.J., Stimson, E., Henderson, J.M., and Halliday, G.M., 2002, Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease, Brain 125:2431–2445.PubMedCrossRefGoogle Scholar
  24. Hardman, C.D., and Halliday, G.M., 1999a, The external globus pallidus in patients with Parkinson’s disease and progressive supranuclear palsy, Mov. Disord. 14:626–633.PubMedCrossRefGoogle Scholar
  25. Hardman, C.D., and Halliday, G.M., 1999b, The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson’s disease, Exp. Neurol. 158:135–142.PubMedCrossRefGoogle Scholar
  26. Hardman, C.D., Halliday, G.M., McRitchie, D.A., Cartwright, H.R., and Morris, J.G.L., 1997a, Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata, Exp. Neurol. 144:183–192.PubMedCrossRefGoogle Scholar
  27. Hardman, C.D., McRitchie, D.A., Halliday, G.M., Cartwright, H.R., and Morris, J.G.L., 1996, The substantia nigra pars reticulata in Parkinson’s disease, Neurodegeneration 5:49–55.PubMedCrossRefGoogle Scholar
  28. Hardman, C.D., McRitchie, D.A., Halliday, G.M., and Morris, J.G.L., 1997b, The subthalamic nucleus in Parkinson’s disease and progressive supranuclear palsy, J. Neuropathol. Exp. Neurol. 56:132–142.PubMedGoogle Scholar
  29. Hauw, J., Verny, M., Delaere, P., Cervera, P., He, Y., and Duyckaerts, C., 1990, Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy: Basic differences with Alzheimer’s disease and aging, Neurosci. Lett. 119:182–186.PubMedCrossRefGoogle Scholar
  30. Henderson, J.M., Carpenter, K., Cartwright, H., and Halliday, G.M., 2000a, Degeneration of the centre median-parafascicular complex in Parkinson’s disease, Ann. Neurol. 47:345–352.PubMedCrossRefGoogle Scholar
  31. Henderson, J.M., Carpenter, K., Cartwright, H., and Halliday, G.M., 2000b, Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson’s disease: clinical and therapeutic implications, Brain 123:1410–1421.PubMedCrossRefGoogle Scholar
  32. Hirsch, E.C., Graybiel, A.M., Duyckaerts, C., and Javoy-Agid, F., 1987, Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson’s disease and progressive supranuclear palsy, Proc. Natl. Acad. Sci. U.S.A. 84:5976–5981.PubMedCrossRefGoogle Scholar
  33. Jellinger, K., 1988, The pedunculopontine nucleus in Parkinson’s disease, progressive supranuclear palsy and Alzheimer’s disease, J. Neurol. Neurosurg. Psychiatry 51:540–543.PubMedCrossRefGoogle Scholar
  34. Jones, E.G., 1985, The Thalamus, New York: Plenum Press.Google Scholar
  35. Jones, E.G., and Hendry, S.H.C., 1989, Differential calcium binding protein immunoreactivity distinguishes classes of relay neurons in monkey thalamic nuclei, Eur. J. Neurosci. 1(3):222–246.PubMedCrossRefGoogle Scholar
  36. Juh, R., Kim, J., Moon, D., Choe, B., and Suh, T., 2004, Different metabolic patterns analysis of Parkinsonism on the [18]F-FDG PET, Eur. J. Radiol. 51:223–233.PubMedCrossRefGoogle Scholar
  37. Kim, R., Nakano, K., Jayaraman, A., and Carpenter, M.B., 1976, Projections of the globus pallidus and adjacent structures: an autoradiographic study in the monkey, J. Comp. Neurol. 1976:263–290.CrossRefGoogle Scholar
  38. Kofler, M.J.M., Reggiani, L., and Wenning, G.K., 2000, Somatosensory evoked potentials in progressive supranuclear palsy, J. Neurol. Sci. 179:85–91.PubMedCrossRefGoogle Scholar
  39. Kuhn, A.A., Grosse, P., Holtz, K., Brown, P., Meyer, B.U., and Kupsch, A., 2004, Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes, Clin. Neurophysiol. 115:1786–1795.PubMedCrossRefGoogle Scholar
  40. Lewy, F.H., 1913, Zur pathologischen anatomie der Paralysis Agitans, Dtsh. Z. Nervenheilk. 50:50–55.Google Scholar
  41. Li, F., Iseki, E., Odawara, T., Kosaka, K., Yagashita, S., and Amano, N., 1998, Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer’s disease, J. Neurol. Sci. 159:73–81.PubMedCrossRefGoogle Scholar
  42. Litvan, I., 1998, Progressive supranuclear palsy revisited, Acta Neurol. Scand. 98:73–84.CrossRefGoogle Scholar
  43. Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R.C., Goetz, C., Golbe, L.I., Grafman, J., Growdon, J.H., Hallet, M., Jankovic, J., Quinn, N.P., Tolosa, E., and Zee, D.S., 1996a, Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop, Neurology 47:1–9.PubMedGoogle Scholar
  44. Litvan, I., Campbell, G., Mangone, C.A., Verny, M., McKee, A., Chaudhuri, K.R., Jellinger, K., Pearce, R.K.B., and D’Olhaberriague, L., 1997, Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study, Brain 120:65–74.PubMedCrossRefGoogle Scholar
  45. Litvan, I., Hauw, J.J., Bartko, J.J., Lantos, P.L., Daniel, S.E., Horoupian, D.S., McKee, A., Dickson, D., Bancher, C., Tabaton, M., Jellinger, K., and Anderson, D.W., 1996b, Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders, J. Neuropathol. Exp. Neurol. 55:97–105.PubMedGoogle Scholar
  46. Macchi, G., and Jones, E.G., 1997, Toward an agreement on terminology of nuclear and subnuclear divisions of the motor thalamus, J. Neurosurg. 86:670–685.PubMedCrossRefGoogle Scholar
  47. MacDonald, V., and Halliday, G.M., 2002, Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson’s disease, Mov. Disord. 17(6):1166–1173.PubMedCrossRefGoogle Scholar
  48. McFarland, N.R., and Haber, S.N., 2000, Convergent inputs from thalamic motor nuclei and frontal cortical areas to the dorsal striatum in the primate, J. Neurosci. 20(10):3798–3813.PubMedGoogle Scholar
  49. Mouroux, M., and Féger, J., 1993, Evidence that the parafascicular projection to the subthalamic nucleus is glutaminergic, NeuroReport 4:613–615.PubMedGoogle Scholar
  50. Münkle, M.C., Waldvogel, H.J., and Faull, R.L.M., 1999, Calcium binding protein immunoreactivity delineates the intralaminar nuclei of the thalamus in the human brain, Neuroscience 90:485–491.PubMedCrossRefGoogle Scholar
  51. Naidich, T.P., Hof, P.R., Yousry, T.A., and Yousry, I., 2001, The motor cortex: anatomic substrates of function, Neuroimaging Clin. N. Am. 11:171–193.PubMedGoogle Scholar
  52. Nakano, K., Hasegawa, Y., Kayahara, T., and Kuga, Y., 1991, Topographical organisation of the thalamostriatal projection in the Japanese monkey, Macaca fuscata, with special reference to the centremedian-parafascicular and motor thalamic nuclei, In: Beradi, G., Carpenter, M.B., Di Chiara, G., Morelli, M., and Stanzione, P., editors, The Basal Ganglia III, New York: Plenum Press, p 6–72.Google Scholar
  53. Nauta, W., and Mehler, W., 1966, Projections of the lentiform nuclei in the monkey, Brain Res. 1:3–42.PubMedCrossRefGoogle Scholar
  54. Nishimura, T., Ikeda, K., Akiyama, H., Kondo, H., Kato, M., Li, F., et al., 1995, Immunohistochemical investigation of tau-positive structures in the cerebral cortex of patients with progressive supranuclear palsy, Neurosci. Lett. 210:123–126.CrossRefGoogle Scholar
  55. Ohye, C., Shibazaki, T., Hirai, T., Kawashima, Y., Hirato, M., and Matsumura, M., 1993, Tremor-mediating thalamic zone studied in humans and in monkeys, Stereotact. Funct. Neurosurg. 60:136–145.PubMedGoogle Scholar
  56. Okuda, B., Tachibana, H., Kawabata, K., Takeda, M., and Sugita, M., 2000, Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy, Alzheimer Dis. Assoc. Disord. 14:46–52.PubMedGoogle Scholar
  57. Parkinson, J., 1817, Essay on the Shaking Palsy, London: Sherwood, Neely and Jones.Google Scholar
  58. Picard, N., and Strick, P.L., 2001, Imaging the premotor areas, Curr. Opin. Neurobiol. 11:663–672.Google Scholar
  59. Piccini, P., Yebenez, J., Lees, A.J., Ceravolo, R., Turjanski, N., Pramstaller, P., et al., 2001, Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography, Arch. Neurol. 58:1846–1851.PubMedCrossRefGoogle Scholar
  60. Rowe, J., Stephen, K.E., Friston, K., Frackowiak, R., Lees, A., and Passingham, R., 2002, Attention to action in Parkinson’s disease. Impaired effective connectivity among frontal cortical regions, Brain 125:276–289.PubMedCrossRefGoogle Scholar
  61. Sabatini, U., Boulanouar, K., Martin, F., Carel, C., Colonese, C., Bozzao, L., et al., 2000, Cortical motor reorganisation in akinetic patients with Parkinson’s disease: A functional MRI study, Brain 123:394–403.PubMedCrossRefGoogle Scholar
  62. Sadikot, A., Parent, A., and Francois, C., 1992, Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a PHA-L study of subcortical projections, J. Comp. Neurol. 315:137–159.PubMedCrossRefGoogle Scholar
  63. Salmon, E., Van der Linden, M., and Franck, G., 1997, Anterior cingulate and motor network impairment in progressive supranuclear palsy, Neuroimage 5:173–178.PubMedCrossRefGoogle Scholar
  64. Schell, G.R., and Strick, P.L., 1984, The origin of thalamic inputs to the arcuate premotor and supplementary motor areas, J. Neurosci. 4(2):539–560.PubMedGoogle Scholar
  65. Sidibé, M., Paré, J-F., Raju, D., and Smith, Y., 2002, Anatomical and functional relationships between intralaminar thalamic nuclei and basal ganglia in monkeys. In: Nicholson LB, and Faull RLM, editors. The basal ganglia VII, New York: Kluver Academic/Plenum Publishers, p 409–420.Google Scholar
  66. Sidibé, M., and Smith, Y., 1999, Thalamic inputs to striatal interneurons in monkeys: synaptic organization and co-localization of calcium binding proteins, Neuroscience 89(4):1189–1208.PubMedCrossRefGoogle Scholar
  67. Smith, Y., Raju, D.V., Paré, J-F., and Sidibé, M., 2004, The thalamostriatal system: a highly specific network of the basal ganglia circuitry, Trends Neurosci. 27(9):520–527.PubMedCrossRefGoogle Scholar
  68. Steele, J.C., Richardson, J.C., and Olszewski, J., 1964, Progressive supranuclear palsy: a heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia, Arch. Neurol. 10:333–359.PubMedGoogle Scholar
  69. Thobois, S., Dominey, P., Decety, J., Pollak, P., Gregoire, M., Le Bars, D., et al., 2000, Motor imagery in normal subjects and in asymmetrical Parkinson’s disease: A PET study, Neurology 55:996–1002.PubMedGoogle Scholar
  70. Tsuboi, Y., Slowinski, J., Josephs, K.A., Honer, W.G., Wszolek, Z.K., and Dickson, D.W., 2003, Atrophy of superior cerebellar peduncle in progressive supranuclear palsy, Neurology 60:1766–1769.PubMedGoogle Scholar
  71. Vermesch, P., Robitaille, Y., Bernier, L., Wattez, A., Gauvreau, D., and Delacourte, A., 1994, Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement, Acta Neuropathol. 87:572–577.CrossRefGoogle Scholar
  72. Verny, M., Duyckaerts, C., Agid, Y., and Hauw, J.J., 1996, The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases, Brain 119:1123–1136.PubMedGoogle Scholar
  73. Wenning, G.K., Ebersbach, G., Verny, M., Chaudhuri, K.R., Jellinger, K., McKee, A., Poewe, W., and Litvan, I., 1999, Progression of falls in postmortem-confirmed parkinsonian disorders, Mov. Disord. 14(6):947–950.PubMedCrossRefGoogle Scholar
  74. Xuereb, J.H., Perry, R.H., Candy, J.M., Perry, E.K., Marshall, E., and Bonham, J.R., 1991, Nerve cell loss in the thalamus in Alzheimer’s disease and Parkinson’s disease, Brain 114:1363–1379.PubMedGoogle Scholar
  75. Zweig, R.M., Whitehouse, P.J., Casanova, M.F., Walker, L.C., Jankel, W.R., and Price, D.L., 1987, Loss of pedunculopontine neurons in progressive supranuclear palsy, Ann. Neurol. 22:18–25.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Jasmine M. Henderson
    • 1
  • Virginia Macdonald
    • 2
  • Glenda M. Halliday
    • 2
  1. 1.Dept of PharmacologyUniversity of SydneyAustralia
  2. 2.Neuropathology Lab.Prince of Wales Medical Research InstituteRandwickAustralia

Personalised recommendations